Cargando…
High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study
BACKGROUND: Albuminuria has been widely considered a risk factor for cardiovascular diseases (CVDs), which is associated with hypertension (HTN), type 2 diabetes mellitus (T2DM), HTN with T2DM, and dyslipidemia. However, the associations between albuminuria and HTN, T2DM, HTN with T2DM, dyslipidemia...
Autores principales: | Wang, Jie, Wang, Yun, Li, Yijun, Hu, Ying, Jin, Lingzi, Wang, Weiqing, Gao, Zhengnan, Tang, Xulei, Yan, Li, Wan, Qin, Luo, Zuojie, Qin, Guijun, Chen, Lulu, Gu, Weijun, Lyv, Zhaohui, Mu, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165688/ https://www.ncbi.nlm.nih.gov/pubmed/35669685 http://dx.doi.org/10.3389/fendo.2022.864562 |
Ejemplares similares
-
Lipid Accumulation Product is Associated with Urinary Albumin-creatinine Ratio in Chinese Prediabitic Population: A Report from the REACTION Study
por: Liu, Yang, et al.
Publicado: (2021) -
Association between obesity and urinary albumin-creatinine ratio in the middle-aged and elderly population of Southern and Northern China: a cross-sectional study
por: Qin, Shan, et al.
Publicado: (2021) -
A novel index, Chinese visceral adiposity index is closely associated with urinary albumin‐creatinine ratio in Chinese community adults, especially in hypertensive or hyperglycemic population: Results from the REACTION study
por: Li, Binqi, et al.
Publicado: (2022) -
The association between a body shape index and elevated urinary albumin–creatinine ratio in Chinese community adults
por: Zhang, Yue, et al.
Publicado: (2022) -
Association between metabolic phenotype and urinary albumin‐creatinine ratio in Chinese community adults: A cross‐sectional study
por: Zhang, Yue, et al.
Publicado: (2022)